Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Rule 38.5 - Pfizer INC

23 Nov 2015 10:58

RNS Number : 6074G
Morgan Stanley & Co. Int'l plc
23 November 2015
Β 

ο»Ώ

Β 

Β FORM 38.5(a)

Β 

IRISHΒ TAKEOVERΒ PANEL

Β 

DISCLOSUREΒ UNDERΒ RULEΒ 38.5(a)Β OFΒ THEΒ IRISHΒ TAKEOVERΒ PANELΒ ACT,Β 1997, TAKEOVER Β RULES,Β 2013

Β 

DEALINGS BY CONNECTEDΒ EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARYΒ STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

Β 

Β 

1. KEYΒ INFORMATION

Β Name of exempt market-maker

Morgan Stanley & Co. International plc

Β Company dealt in

PFIZER INC

Β Class of relevant security to which the dealings being disclosed relate (Note 1)

US$0.05 COMMON STOCK

Β Date of dealing

20 NOVEMBER 2015

Β 

Β 

2. DEALINGSΒ (NoteΒ 2)

Β 

(a) PurchasesΒ andΒ sales

Β Total number of relevant secuities accquired

Β Highest price paid (Note 3)

Β Lowest price paid (Note 3)

Β Β 360

Β 30.2000 EUR

Β 30.0950 EUR

Β Β 43,089

Β 32.5500 USD

Β 32.1000 USD

Β 

Β Total number of relevant secuities disposed

Β Highest price paid (Note 3)

Β Lowest price paid (Note 3)

Β Β 290

Β 30.3000 EUR

Β 30.2000 EUR

Β Β 43,089

Β 32.5500 USD

Β 32.1000 USD

Β 

Β 

(b) DerivativesΒ transactionsΒ (otherΒ thanΒ optionsΒ transactions)

Β 

Β Product name, e.g. CFD

Β Nature of transaction

(Note 4)

Β Number of relevant securities

(Note 5)

Β Price per unit

Β CFD

Β LONG

Β 40

Β 30.3000 EUR

Β CFD

Β SHORT

Β 110

Β 30.0950 EUR

Β CFD

Β LONG

Β 753

Β 32.1800 USD

Β CFD

Β LONG

Β 829

Β 32.4254 USD

Β CFD

Β SHORT

Β 100

Β 32.1550 USD

Β CFD

Β SHORT

Β 200

Β 32.1550 USD

Β CFD

Β SHORT

Β 200

Β 32.1550 USD

Β CFD

Β SHORT

Β 1,215

Β 32.1800 USD

Β CFD

Β SHORT

Β 4,155

Β 32.1800 USD

Β CFD

Β SHORT

Β 785

Β 32.1800 USD

Β CFD

Β SHORT

Β 479,233

Β 32.4448 USD

Β CFD

Β SHORT

Β 2,781

Β 32.5500 USD

Β 

Β 

(c) OptionsΒ transactionsΒ inΒ respectΒ ofΒ existingΒ relevantΒ securities

Β 

i) Writing,Β selling,Β purchasingΒ orΒ varying

Β 

Β Product name, eg call option

Β Writing, selling, purchasing, varying etc

Β Number of securities to which the option relates (Note 5)

Β Exercise Price

Β Type, e.g American, European etc

Β Expiry Date

Β Option money paid/received per unit (Note 3)

Β CALL

Β SALE

Β 4,350,000

Β 1.0000

Β E

Β 30/11/2018

Β 1.1000 SEK

Β CALL

Β PURCHASE

Β 501,730

Β 1.0000

Β E

Β 30/11/2018

Β 0.9999 USD

Β 

(ii) Exercising

Β 

Β Product name, eg call option

Β Number of securities

Β Exercise price per unit (Note 3)

Β N/A

Β N/A

Β N/A

Β 

Β 

3. OTHER INFORMATION

Β 

Agreements, arrangements or understandings relating to options or derivatives

Β 

Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β Date of disclosure

Β 23 NOVEMBER 2015

Β Contact Name

Craig Horsley

Β Telephone Number

+44(141) 245 7736

Β Name of offeree/offeror with which connected

ALLERGAN PLC

Nature of connection (Note 6)

Advisory

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ISEPKNDPKBDDPDB
Date   Source Headline
11th Nov 20153:04 pmRNSForm 8.3 - Pfizer Inc
11th Nov 20152:59 pmRNSForm 8.3 - Pfizer Inc Amendment
11th Nov 20152:44 pmRNSForm 8.3 - Allergan Plc
11th Nov 20151:45 pmRNSForm 8.1(a) - Pfizer Inc.
11th Nov 201512:45 pmRNSForm 8.3 - Allergan plc
11th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc
11th Nov 201511:52 amRNSForm 38.5(b) - Pfizer Inc
11th Nov 201511:01 amRNSRule 38.5 - Pfizer INC
11th Nov 201510:47 amRNSForm 8.1 - [Pfizer Inc]
11th Nov 201510:44 amRNSForm 38.5b
11th Nov 201510:41 amRNSForm 38.5a
10th Nov 20155:19 pmRNSRule 38.5 - Replacement Pfizer INC
10th Nov 20153:29 pmRNSForm 8.3 - Pfizer Inc
10th Nov 20153:23 pmRNSForm 8.3 - Pfizer Inc
10th Nov 20153:16 pmRNSForm 8.3 - [PFIZER INC]
10th Nov 20153:12 pmRNSForm 8.3 - Allergan plc
10th Nov 20153:04 pmRNSForm 8.3 - Pfizer Inc
10th Nov 20152:54 pmRNSForm 8.3 - Pfizer, Inc.
10th Nov 20152:45 pmRNSForm 8.3 - Allergan Plc
10th Nov 20152:31 pmRNSForm 8.3 - ALLERGAN PLC
10th Nov 20152:28 pmRNSForm 8.3 - PFIZER INC
10th Nov 20152:12 pmBUSForm 8.3 - Pfizer Inc.
10th Nov 201512:35 pmRNSForm 38.5(b) - Pfizer Inc
10th Nov 201512:13 pmRNSForm 38.5b
10th Nov 201512:10 pmRNSForm 38.5b
10th Nov 201512:05 pmRNSForm 38.5a
10th Nov 201512:02 pmRNSForm 8.1 - [Pfizer Inc]
10th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc.
10th Nov 201511:16 amRNSRule 38.5 - Pfizer INC
10th Nov 201511:11 amRNSRule 38.5 - Replacement Pfizer INC
10th Nov 201511:10 amRNSRule 38.5 - Replacement Pfizer INC
9th Nov 20154:30 pmRNSForm 8.3 - Allergan plc
9th Nov 20153:44 pmRNSForm 8.3 - PFIZER INC
9th Nov 20153:33 pmRNSForm 8.3 - Pfizer Inc
9th Nov 20153:25 pmRNSForm 8.3 - Pfizer Inc
9th Nov 20153:24 pmRNSForm 8.3 - Pfizer Inc Amendment
9th Nov 20153:16 pmRNSForm 8.3 - [PFIZER INC]
9th Nov 20152:58 pmRNSForm 8.3 - ALLERGAN PLC
9th Nov 20152:48 pmRNSForm 8.3 - Pfizer, Inc.
9th Nov 20152:37 pmRNSForm 8.3 - Pfizer Inc
9th Nov 20152:26 pmRNSForm 8.3 - Allergan Plc
9th Nov 201512:02 pmRNSForm 38.5b
9th Nov 201511:59 amRNSForm 38.5b
9th Nov 201511:56 amRNSForm 38.5a
9th Nov 201511:55 amRNSForm 8.1 - [Pfizer Inc]
9th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc.
9th Nov 201511:41 amRNSForm 38.5(b) - Pfizer Inc.
9th Nov 201510:58 amRNSRule 38.5 - Pfizer INC
9th Nov 201510:56 amRNSRule 38.5 - Pfizer INC
6th Nov 20154:16 pmRNSRule 38.5 - Replacement Pfizer INC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.